Clinical trial
Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced…
NCT00293098 · Children's Hospital of Philadelphia, Other · Approved for marketing
Key facts
| NCT number | NCT00293098 |
|---|---|
| Title | Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease |
| Official title | Compassionate Use of Deferiprone in Patients With Thalassemia and Iron-Induced Heart Disease |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Collaborators | ApoPharma Industry |
| Status | Approved for marketing |
| Study type | Expanded Access |
| Conditions | Iron Overload |
| Intervention type | Drug |
| Interventions | deferiprone |
| Start date | Mar 1, 2006 |
| First posted | Feb 17, 2006 |
| Last update posted | Feb 9, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: